NCT02868151View on ClinicalTrials.gov

Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

October 31, 2018

Conditions
Oral Mucositis
Interventions
DRUG

Ascorbic Acid

Ascorbic acid oral supplementation 1g four times daily for the entire treatment period and 30 days after treatment by tapering the dose of the drug to half. The drug has to be started 2 days prior to initiation of treatment of cancer.

DRUG

Zinc acetate

Zinc acetate 50mg tablets orally twice daily for entire period of cancer treatment

Trial Locations (1)

500004

MNJ institute of oncology & regional cancer center, Hyderabad

All Listed Sponsors
collaborator

Saveetha University

OTHER

collaborator

MNJ Institute of Oncology and Regional Cancer Center

OTHER_GOV

lead

Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre

OTHER

NCT02868151 - Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers | Biotech Hunter | Biotech Hunter